Skip to main content

and
  1. No Access

    Article

    A transcriptomic model for homologous recombination deficiency in prostate cancer

    Tumors with mutations associated with homologous recombination deficiency (HRD) are uncommon in prostate cancer (PCa) and variably responsive to PARP inhibition. To better identify tumors with HRD, we develope...

    Adam B. Weiner, Yang Liu, Matthew McFarlane in Prostate Cancer and Prostatic Diseases (2022)